<?xml version="1.0" encoding="UTF-8"?>
<p>Herein, we evaluate the efficacy of HAI FUDR 
 <italic>via</italic> a radiologically implanted pump in patients who had pancreatic cancer liver metastases (PCLM) in two centers. The primary aim was to compare overall survival (OS) from HAI plus SCT 
 <italic>versus</italic> SCT alone. The second aims were to evaluate the short-term effect and functionality of HAI pump system.
</p>
